Literature DB >> 23642360

Patents and misplaced angst: lessons for translational stem cell research from genomics.

Debra J H Mathews1, Robert Cook-Deegan, Tania Bubela.   

Abstract

Realizing the therapeutic potential of both stem cell and genomics research requires harnessing the respective strengths of academic, biotechnology, and pharmaceutical sectors, supported by policies and legal incentives for multisectorial collaboration. Here, we discuss issues facing these fields and lessons from the genomics sector that apply to stem cell research.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23642360      PMCID： PMC3776312          DOI： 10.1016/j.stem.2013.04.015

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  10 in total

1.  Intellectual property. Patents, secrecy, and DNA.

Authors:  R M Cook-Deegan; S J McCormack
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

Review 2.  Recalibrating intellectual property rights to enhance translational research collaborations.

Authors:  Tania Bubela; Garret A FitzGerald; E Richard Gold
Journal:  Sci Transl Med       Date:  2012-02-22       Impact factor: 17.956

Review 3.  Stem cells--a hard sell to investors.

Authors:  Lutz B Giebel
Journal:  Nat Biotechnol       Date:  2005-07       Impact factor: 54.908

4.  The global stem cell patent landscape: implications for efficient technology transfer and commercial development.

Authors:  Karl Bergman; Gregory D Graff
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

5.  Opening stem cell research and development: a policy proposal for the management of data, intellectual property, and ethics.

Authors:  David E Winickoff; Krishanu Saha; Gregory D Graff
Journal:  Yale J Health Policy Law Ethics       Date:  2009

6.  Open science versus commercialization: a modern research conflict?

Authors:  Timothy Caulfield; Shawn He Harmon; Yann Joly
Journal:  Genome Med       Date:  2012-02-27       Impact factor: 11.117

7.  Intellectual property rights and innovation: Evidence from the human genome.

Authors:  Heidi L Williams
Journal:  J Polit Econ       Date:  2010-07-01

8.  Access to stem cells and data: persons, property rights, and scientific progress.

Authors:  Debra J H Mathews; Gregory D Graff; Krishanu Saha; David E Winickoff
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

9.  Distribution of human embryonic stem cell lines: who, when, and where.

Authors:  Jennifer B McCormick; Jason Owen-Smith; Christopher Thomas Scott
Journal:  Cell Stem Cell       Date:  2009-02-06       Impact factor: 24.633

10.  Myriad Genetics: In the eye of the policy storm.

Authors:  E Richard Gold; Julia Carbone
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822
  10 in total
  2 in total

1.  The global intellectual property landscape of induced pluripotent stem cell technologies.

Authors:  MacKenna Roberts; Ivan B Wall; Ian Bingham; Dominic Icely; Brock Reeve; Kim Bure; Anna French; David A Brindley
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

2.  Use and misuse of material transfer agreements: lessons in proportionality from research, repositories, and litigation.

Authors:  Tania Bubela; Jenilee Guebert; Amrita Mishra
Journal:  PLoS Biol       Date:  2015-02-03       Impact factor: 8.029
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.